SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-045972
Filing Date
2018-02-14
Accepted
2018-02-14 17:29:18
Documents
6
Period of Report
2018-02-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d541416d8k.htm 8-K 17133
2 EX-1.1 d541416dex11.htm EX-1.1 222262
3 EX-5.1 d541416dex51.htm EX-5.1 10185
4 EX-99.1 d541416dex991.htm EX-99.1 13828
5 GRAPHIC g541416g0214211103039.jpg GRAPHIC 2962
6 GRAPHIC g541416g30f46.jpg GRAPHIC 3535
  Complete submission text file 0001193125-18-045972.txt   273937
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 18613942
SIC: 8731 Services-Commercial Physical & Biological Research